By Duke Medicine News and Communications
Many new and innovative approaches to treating Parkinson's
disease are on the horizon, including the so-called
'Parkinson's patch.'
"It's a similar idea to a nicotine patch or a nitroglycerine
patch that heart patients use," says Burton
Scott, M.D., assistant clinical professor of neurology at
the Movement
Disorders Clinic at Duke University Medical Center. "It's a
way to deliver a steady dose of Parkinson's medication, so that
the level of that medication is relatively stable."
The Parkinson's patch is currently in the final stage of
clinical trials and could be approved by the FDA within three
years, Scott says. He adds that the device could greatly
simplify the lives of many Parkinson's patients:
"They can replace many of the pills that they have to take,
potentially, with a patch form that's placed on the body once a
day and then taken off once a day."
There is no cure for Parkinson's, although there are
currently medications that are very effective in treating its
symptoms. These medications don't slow the progression of the
disease, but do allow Parkinson's patients to function well for
a long period of time, even decades.
Parkinson's disease is a progressive degenerative disease
that affects more than 1 million Americans. The disease
originates in the substantia nigra, an area deep in the brain
that produces dopamine, a chemical that helps coordinate
movement and muscle control.
In a Parkinson's patient, the cells that produce dopamine
die off, leading to the gradual onset of tremors -- especially
at rest -- often with stiffness and rigidity. Slowness of
movement and difficulty with balance are also frequent
symptoms.
The most common age for developing Parkinson's is in one's
50s, although the disease can strike anyone from their 30s to
their 70s. Early-onset Parkinson's usually refers to the
disease's appearance before age 40.
As Parkinson's disease progresses, the brain makes less and
less dopamine and it becomes increasingly difficult for
medications to replace the chemical. This means many patients
need more and more medications on an increasingly complicated
regimen, in order to maintain their normal level of
functioning.
One of the chronic problems for people suffering from
Parkinson's is ensuring that the levels of medication to treat
their symptoms are consistent and uniform. When dosage levels
fluctuate, the result can sometimes be ineffective treatment
and negative side effects, Scott says.